Clinical trials: Neuropathic Pain From Lumbosacral Radiculopathy
Pain, Neuropathic
Efficacy Study in Lumbosacral Radiculopathy
This study will be a double-blind, placebo-controlled, parallel group study. After enrolment and initial assessments, subjects will receive 35 days of study medication.
- Trial name
- NCT01110057
- Testing
- GS856553
- Where
- 17 sites in Denmark, France and 3 more
- Volunteers
- 142 people
- Sponsor
- GlaxoSmithKline
Lumbosacral Radiculopathy, Neuropathic Pain From Lumbosacral Radiculopathy
TFESI and Neuropathic Pain in Lumbosacral Radiculopathy
Patients with lumbosacral radiculopathy frequently experience neuropathic pain due to nerve root compression. Transforaminal epidural steroid injection (TFESI) is commonly used for pain relief in these patients.
- Conditions
- Lumbosacral Radiculopathy, Neuropathic Pain From Lumbosacral Radiculopathy, Disc Herniation With Radiculopathy
- Trial name
- NCT07799155
- Testing
- Transforaminal Epidural Steroid Injections
- Where
- Turkey (Türkiye)
- Volunteers
- 40 people
- Sponsor
- Marmara University
Lumbosacral Radiculopathy
Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy
The primary objective of the study is to evaluate the efficacy of two dose regimens of BIIB074 on neuropathic pain in participants with pain from lumbosacral radiculopathy (PLSR).
- Trial name
- RELAY-1 (NCT02935608)
- Testing
- BIIB074
- Where
- 56 sites in Austria, Belgium and 12 more
- Volunteers
- 502 people
- Sponsor
- Biogen
Lumbosacral Radiculopathy
Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
The study is a randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy.
- Trial name
- NCT01561027
- Testing
- CNV1014802
- Where
- 12 sites in Czechia, Denmark and 2 more
- Volunteers
- 82 people
- Sponsor
- Biogen
Neuropathic Pain From Lumbosacral Radiculopathy
Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031
- Trial name
- NCT04238793
- Testing
- KLS-2031
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Kolon Life Science
Neuropathic Pain From Lumbosacral Radiculopathy
Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB074 in participants with neuropathic Pain From Lumbosacral Radiculopathy (PLSR).
- Trial name
- RELAY-1 Extend (NCT02957617)
- Testing
- BIIB074
- Where
- 51 sites in Austria, Belgium and 12 more
- Volunteers
- 302 people
- Sponsor
- Biogen
Lumbosacral Radiculopathy
Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
This study will compare Z160 and placebo in patients with Lumbosacral Radiculopathy for safety and efficacy for a period of 6 weeks.
- Trial name
- NCT01655849
- Testing
- z160
- Where
- 23 sites in United States
- Volunteers
- 141 people
- Sponsor
- Zalicus